The QIAstat should accelerate growth for the diagnostic testing company.
News & Analysis: Qiagen N.V.
QGEN earnings call for the period ending March 31, 2019.
With new products, growth at the diagnostic test company is set to accelerate this year.
QGEN earnings call for the period ending December 31, 2018.
With lackluster growth, the diagnostic test and lab supplier acquired an option to get into a new diagnostic test market.
QGEN earnings call for the period ending September 30, 2018.
Earnings grow faster than revenue as the diagnostic test company keeps costs in check.
The launch of QIAstat-Dx should help accelerate growth in the second half of the year.
Restructuring is helping the scientific-test maker to become more efficient.
But investors would have liked to have seen more.